Boston189 tumours, from patients in their 20s to 90s, now form one colorectal atlas.
Patients under 35 may survive worse than those in their 40s or 60s despite harsher treatment, Dana-Farber’s Kimmie Ng says.
The Nature Medicine study profiles each tumour’s cells individually, letting researchers control for variables that confounded earlier comparisons of younger and older patients.
Whether young-onset tumours are biologically distinct, as clinicians long believed, is what the atlas lets researchers test.
How each outlet framed it
- STAT
- foregrounds the survival paradox that under-35s may fare worse than patients in their 40s and 60s despite more aggressive treatment
Sources: STAT